SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SRT3 - DE0007165631
249.6 EUR
-6.6 (-2.58%)
We assign a fundamental rating of 3 out of 10 to SRT3. SRT3 was compared to 22 industry peers in the Life Sciences Tools & Services industry. SRT3 may be in some trouble as it scores bad on both profitability and health. SRT3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year SRT3 was profitable.
- SRT3 had a positive operating cash flow in the past year.
- In the past 5 years SRT3 has always been profitable.
- Each year in the past 5 years SRT3 had a positive operating cash flow.
1.2 Ratios
- SRT3's Return On Assets of 1.39% is on the low side compared to the rest of the industry. SRT3 is outperformed by 77.27% of its industry peers.
- SRT3 has a worse Return On Equity (5.01%) than 68.18% of its industry peers.
- SRT3 has a worse Return On Invested Capital (4.71%) than 72.73% of its industry peers.
- SRT3 had an Average Return On Invested Capital over the past 3 years of 8.34%. This is in line with the industry average of 9.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
- SRT3 has a worse Profit Margin (3.80%) than 77.27% of its industry peers.
- SRT3's Profit Margin has declined in the last couple of years.
- SRT3's Operating Margin of 14.06% is on the low side compared to the rest of the industry. SRT3 is outperformed by 63.64% of its industry peers.
- In the last couple of years the Operating Margin of SRT3 has declined.
- SRT3's Gross Margin of 46.48% is fine compared to the rest of the industry. SRT3 outperforms 63.64% of its industry peers.
- In the last couple of years the Gross Margin of SRT3 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRT3 is destroying value.
- SRT3 has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for SRT3 has been increased compared to 5 years ago.
- Compared to 1 year ago, SRT3 has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.52 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.52, SRT3 is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
- The Debt to FCF ratio of SRT3 is 8.92, which is on the high side as it means it would take SRT3, 8.92 years of fcf income to pay off all of its debts.
- SRT3 has a Debt to FCF ratio of 8.92. This is in the lower half of the industry: SRT3 underperforms 63.64% of its industry peers.
- SRT3 has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
- SRT3 has a worse Debt to Equity ratio (1.28) than 77.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.52 |
ROIC/WACC0.54
WACC8.8%
2.3 Liquidity
- SRT3 has a Current Ratio of 0.95. This is a bad value and indicates that SRT3 is not financially healthy enough and could expect problems in meeting its short term obligations.
- SRT3 has a worse Current ratio (0.95) than 86.36% of its industry peers.
- A Quick Ratio of 0.49 indicates that SRT3 may have some problems paying its short term obligations.
- SRT3 has a Quick ratio of 0.49. This is amonst the worse of the industry: SRT3 underperforms 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
- SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
- The earnings per share for SRT3 have been decreasing by -11.87% on average. This is quite bad
- Looking at the last year, SRT3 shows a small growth in Revenue. The Revenue has grown by 5.82% in the last year.
- SRT3 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.10% yearly.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
- The Earnings Per Share is expected to grow by 18.87% on average over the next years. This is quite good.
- The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y23.18%
EPS Next 2Y21.51%
EPS Next 3Y21.15%
EPS Next 5Y18.87%
Revenue Next Year5.32%
Revenue Next 2Y6.73%
Revenue Next 3Y8.71%
Revenue Next 5Y8.45%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 54.74, SRT3 can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, SRT3 is valued more expensive than 81.82% of the companies in the same industry.
- SRT3 is valuated expensively when we compare the Price/Earnings ratio to 28.87, which is the current average of the S&P500 Index.
- SRT3 is valuated quite expensively with a Price/Forward Earnings ratio of 41.25.
- Based on the Price/Forward Earnings ratio, SRT3 is valued a bit more expensive than the industry average as 77.27% of the companies are valued more cheaply.
- The average S&P500 Price/Forward Earnings ratio is at 25.96. SRT3 is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.74 | ||
| Fwd PE | 41.25 |
4.2 Price Multiples
- SRT3's Enterprise Value to EBITDA ratio is in line with the industry average.
- SRT3's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.05 | ||
| EV/EBITDA | 24.9 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRT3 does not grow enough to justify the current Price/Earnings ratio.
- SRT3's earnings are expected to grow with 21.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.36
PEG (5Y)N/A
EPS Next 2Y21.51%
EPS Next 3Y21.15%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.36%, SRT3 is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.48, SRT3 has a dividend in line with its industry peers.
- With a Dividend Yield of 0.36, SRT3 pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.36% |
5.2 History
- The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 37.92% of the earnings are spent on dividend by SRT3. This is a low number and sustainable payout ratio.
- The dividend of SRT3 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.92%
EPS Next 2Y21.51%
EPS Next 3Y21.15%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
Can you provide the valuation status for SARTORIUS AG-VORZUG?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
What is the valuation of SARTORIUS AG-VORZUG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 54.74 and the Price/Book (PB) ratio is 7.
Can you provide the financial health for SRT3 stock?
The financial health rating of SARTORIUS AG-VORZUG (SRT3.DE) is 1 / 10.